First-of-its-kind AI-based Diagnostics Solutions Approved in Europe
According to the World Health Organisation, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths …
Premium Articles
A Race For Better 3CL Inhibitors to Cure COVID-19: Copies vs. Innovators
Disclaimer: This post is not medical advice and is for informational purposes only. All the information contained here is related …
Understanding the Innovations From LSTM, to an Encoder/Decoder Model, to Transformers; and Their Impact on Health Science
AstraZeneca has achieved outstanding results in drug design using large language models applied to SMILES representation of molecules; but what are …
9 Companies Using Artificial Intelligence to Fight Infectious Diseases
Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, …
Ancient Material Promises To Solve Drug Delivery “Pain”
Vaxess is a venture capital and Gates Foundation-backed company that is developing vaccine patches. Their mission is to significantly increase …
What to Consider Before Launching a Biotech Startup in 2022?
Luciano Santollani is currently working towards his PhD at MIT developing novel cancer therapeutics, and is also working as a …
Current Trends in Nanomedicine: Notable FDA Approvals and Clinical Trials to Follow
Nanomedicines, as it goes from the name, are nanotechnology-based drugs, used for the treatment, diagnosis or prevention of various diseases. …
Toronto’s Blossoming AI-driven Drug Discovery Scene
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
3D Printed Muscle Tissues for Drug Discovery With Mantarray™ Platform by Curi Bio
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
Transformational EGFR Drug Discovery
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
Valo Therapeutics Aims to Improve Personalized Immunotherapy With a New Tech
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
Cyclica's Chemical Probes for DCAF1
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …